RT @Ferhatarslandr: @er53541833 Deyin ki onlara doğum gibi 9 ay illa gerekli mıymış? Allahın emri miymiş INH ? Sorgulanamaz mıymış? Bak bur…
@er53541833 Deyin ki onlara doğum gibi 9 ay illa gerekli mıymış? Allahın emri miymiş INH ? Sorgulanamaz mıymış? Bak burada sorgulamışlar mesela biraz ama biraz https://t.co/EaAk2ZAJ0C
e-nfectologiaped: Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing... http://t.co/yzCouanell
e-nfectologiaped: Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing... http://t.co/eiajopTAt9
e-nfectologiaped: Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing... http://t.co/LHnTM9HsVe
Preventing active #TB from developing in people with #latentTB infection is important for global #TBcontrol http://t.co/rJHCbYSPgc
A new #Cochrane review: Alternatives to #isoniazid monotherapy in HIV-negative people with latent #tuberculosis http://t.co/rJHCbYSPgc
RT @HIVTB: Investigations into shorter alternatives to isoniazid for preventing active #TB look promising http://t.co/rkOWT1U69i #HIV
RT @HIVTB: Investigations into shorter alternatives to isoniazid for preventing active #TB look promising http://t.co/rkOWT1U69i #HIV
RT @HIVTB: Investigations into shorter alternatives to isoniazid for preventing active #TB look promising http://t.co/rkOWT1U69i #HIV
RT @HIVTB: Investigations into shorter alternatives to isoniazid for preventing active #TB look promising http://t.co/rkOWT1U69i #HIV
RT @HIVTB: Investigations into shorter alternatives to isoniazid for preventing active #TB look promising http://t.co/rkOWT1U69i #HIV
Investigations into shorter alternatives to isoniazid for preventing active #TB look promising http://t.co/B8MSLIClbb #HIV
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
Cochrane review compares shorter prophylactic regimens using Rif/RPT with INH to prevent active #TB in HIV- persons http://t.co/um2CjWuJUZ
Cochrane review compares shorter prophylactic regimens using Rif/RPT with INH to prevent active #TB in HIV- persons http://t.co/X51S4UzeGF
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/p7Ep554HWc”
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/p7Ep554HWc”
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
New #CochraneEvidence: rifampicin for 3-4 months may give similar results to 6 months of isoniazid in preventing #TB http://t.co/3lxrXRQrTm
Alternatives to isoniazid monotherapy for preventing active #tuberculosis in #HIV-negative persons http://t.co/c4IePVeQaT @CochraneLibrary
Alternatives to isoniazid monotherapy for preventing active tuberculosis in HIV-negative persons... http://t.co/c4IePVeQaT
Alternatives to isoniazid monotherapy for preventing active tuberculosis in HIV-negative persons... http://t.co/c4IePVeQaT
Current treatment recommendations for treating dormant or latent TB favors the use of Isoniazid for six months.... http://t.co/W9dU2VZzB7
New paper: efficacy of rifampicin is comparable to INH with higher completion and lesser adverse events for HIV -ves. http://t.co/LsyZ5e5EdK
New paper: efficacy of rifampicin is comparable to INH with higher completion and lesser adverse events for HIV -ves. http://t.co/LsyZ5e5EdK
New paper: efficacy of rifampicin is comparable to INH with higher completion and lesser adverse events for HIV -ves. http://t.co/LsyZ5e5EdK
New paper: efficacy of rifampicin is comparable to INH with higher completion and lesser adverse events for HIV -ves. http://t.co/LsyZ5e5EdK
New paper: efficacy of rifampicin is comparable to INH with higher completion and lesser adverse events for HIV -ves. http://t.co/LsyZ5e5EdK
e-nfectologiaped: Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing... http://t.co/KYZ9vs7sNp
New #Cochrane review on drug combinations for preventing #TB in at risk populations - is shorter better? http://t.co/kdJKembtRE